This inventor holds 1 USPTO granted patent. Top assignee: National Dong Hwa University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by Ping-Jyun Sung in Cancer Treatment
Introduction
Ping-Jyun Sung is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compounds. His work focuses on innovative solutions for treating cancer, showcasing his dedication to advancing medical science.
Latest Patents
Ping-Jyun Sung holds a patent for a scalarane sesterterpenoid, which is a pharmaceutical composition and a topoisomerase II and Hsp90 inhibitor for treating cancer. The patent details the extraction of these compounds from specific sponge species and their potential use as anticancer agents. The compounds represented by formula (I) can effectively inhibit topoisomerase II and Hsp90, providing a promising avenue for cancer treatment.
Career Highlights
Sung is affiliated with National Dong Hwa University, where he continues to engage in research and development in the field of pharmaceuticals. His academic background and research initiatives have positioned him as a key figure in the fight against cancer.
Collaborations
He has collaborated with notable colleagues, including Mei-Chin Lu and Jui-Hsin Su, to further enhance the research and development of his innovative pharmaceutical compositions.
Conclusion
Ping-Jyun Sung's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work exemplifies the potential of scientific advancements in improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile